Your browser doesn't support javascript.
loading
Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy.
Márquez-Algaba, Ester; Iacoboni, Gloria; Pernas, Berta; Esperalba, Juliana; Los Arcos, Ibai; Navarro, Victor; Monforte, Arnau; Beas, Francisco; Albasanz-Puig, Adaia; Carpio, Cecilia; Barba, Pere; Ruiz-Camps, Isabel.
Afiliação
  • Márquez-Algaba E; Department of Infectious Diseases, Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Medicine, Universitat Autònoma of Barcelona, Bellaterra, Spain.
  • Iacoboni G; Department of Medicine, Universitat Autònoma of Barcelona, Bellaterra, Spain; Department of Hematology, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Pernas B; Department of Infectious Diseases, University Hospital of A Coruña, Clinical Virology Group, Biomedical Research Institute of A Coruña, A Coruña, Spain.
  • Esperalba J; Department of Microbiology, Vall d'Hebron Research Institut, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Los Arcos I; Department of Infectious Diseases, Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Navarro V; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Monforte A; Department of Infectious Diseases, Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Medicine, Universitat Autònoma of Barcelona, Bellaterra, Spain.
  • Beas F; Department of Hematology, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Albasanz-Puig A; Department of Infectious Diseases, Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Carpio C; Department of Medicine, Universitat Autònoma of Barcelona, Bellaterra, Spain; Department of Hematology, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Barba P; Department of Medicine, Universitat Autònoma of Barcelona, Bellaterra, Spain; Department of Hematology, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain. Electronic address: pbarba@vhio.net.
  • Ruiz-Camps I; Department of Infectious Diseases, Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Medicine, Universitat Autònoma of Barcelona, Bellaterra, Spain.
Transplant Cell Ther ; 28(12): 851.e1-851.e8, 2022 12.
Article em En | MEDLINE | ID: mdl-36221995
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2022 Tipo de documento: Article